Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies to address the unmet needs of the rare disease community.
Location: United States, California, La Jolla
Employees: 51-200
Total raised: $301M
Founded date: 2012
Investors 7
Funding Rounds 4
| Date | Series | Amount | Investors |
| 08.06.2020 | IPO | $150M | - |
| 13.11.2019 | Series C | $100M | - |
| 22.04.2019 | - | $35M | - |
| 05.01.2017 | Series B | $16M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 08.01.2021 | Avidity Biosciences Announces 2021 Pipeline Updates and Rese... | LA JOLLA, Calif., Jan. 8, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharm... | prnewswire... |
| 08.06.2020 | Muscle disorder biotech Avidity Biosciences sets terms for $... | - | fprimecapi... |
| 26.05.2020 | Biotech Muscle disorder biotech Avidity aims for the clinic ... | - | fprimecapi... |
| 13.11.2019 | Avidity Biosciences has raised a $100M Series C to work on t... | - | connect.or... |
| 13.11.2019 | Avidity Biosciences Completes $100 Million Series C Financin... | LA JOLLA, Calif.--(BUSINESS WIRE)--Avidity Biosciences, a biotechnology company pioneering Antibody-... | archive.ci... |
| 13.11.2019 | Avidity Biosciences Completes $100 Million Series C Financin... | JOLLA, Calif.--(BUSINESS WIRE)--Avidity Biosciences, a biotechnology company pioneering Antibody-Oli... | archive.ci... |
| 22.04.2019 | Daily funding roundup - April 22nd, 2019 | Novo Labs raised $2M; Driveroo secured $3.1M; Nabis landed $4M; Bridge Connector closed $20M Novo L... | vator.tv/n... |
| 22.04.2019 | Lilly and Avidity Biosciences Sign Licensing and Research Co... | Eli Lilly and Company (NYSE: LLY) and La Jolla, CA-based Avidity Biosciences, Inc., signed a global ... | finsmes.co... |
| 22.04.2019 | Avidity Biosciences Lands $35M In Deal With Lilly | La Jolla-based Avidity Biosciences, a developer of biopharmaceuticals that uses monoclonal antibodie... | socaltech.... |
| 05.01.2017 | Term Sheet — Thursday, January 5 | THE 21 BEST TECH IPOS of 2016, ETC Visions: SoftBank has been purposely opaque about many aspects o... | fortune.co... |
Show more